4-traders (press release) Vosaroxin is a first-in-class anti-cancer quinolone derivative (AQD), a class of compounds that has not been used previously for the treatment of cancer. Vosaroxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, ...
MarketWatch Vosaroxin is a first-in-class anti-cancer quinolone derivative (AQD), a class of compounds that has not been used previously for the treatment of cancer. Vosaroxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, ... and more »
Seeking Alpha But its unique quinolone backbone gives distinct advantages over other treatment standards both on the efficacy and the safety side. So on the efficacy side it avoid some of the drug resistance pathways and these are particularly troublesome in AML.
